Search results for "Bulk"

showing 10 items of 286 documents

Magnetic molecularly imprinted polymers for the selective determination of cocaine by ion mobility spectrometry

2018

Abstract Magnetic molecularly imprinted polymers (MMIPs) were prepared for cocaine recognition by bulk polymerization in the presence of magnetic nanoparticles (MNPs). Two reagents (polyethylene glycol (PEG) and 3-(trimethoxysilyl)propyl methacrylate (V)) were used for MNPs modification. MMIPs were characterized and compared in terms of loading capacity, reusability, accuracy and precision for the extraction of cocaine from saliva samples. It was observed that V-MMIPs gave higher physical stability than PEG-MMIPs. Thus, V-MMIP were used for the analysis of cocaine users saliva. The developed procedure based on ion mobility spectrometry (IMS) provided limits of detection and quantification o…

AdultMaleBulk polymerizationPolymersIon-mobility spectrometry02 engineering and technologyPolyethylene glycolTandem mass spectrometryMethacrylate01 natural sciencesBiochemistryPolyethylene GlycolsAnalytical ChemistryMolecular ImprintingMagneticsYoung Adultchemistry.chemical_compoundCocaineIon Mobility SpectrometryHumansOrganosilicon CompoundsSalivaChromatography High Pressure LiquidDetection limitChromatography010401 analytical chemistryOrganic ChemistryMolecularly imprinted polymerSignal Processing Computer-AssistedGeneral Medicine021001 nanoscience & nanotechnology0104 chemical scienceschemistryMethacrylatesMagnetic nanoparticlesFemale0210 nano-technologyJournal of Chromatography A
researchProduct

Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Insti…

2014

Purpose: The aim of this study was to investigate whether preoperative laparoscopic evaluation of the dissemination of disease may have an independent impact on survival in advanced epithelial ovarian cancer (AEOC).Methods: All AEOC women were submitted to staging laparoscopy before receiving primary debulking surgery (PDS) or neoadjuvant chemotherapy (NACT). All study women received a laparoscopic score (predictive index value [PIV]) and were stratified into three groups based on volume of disease: high tumor load (HTL) for PIV ≥8, intermediate tumor load (ITL) for PIV equal to 6 and 4, and low tumor load (LTL) for PIV 1 cm in 15 cases (9.1 %). When stratifying the whole population accordi…

AdultOncologymedicine.medical_specialtyNeoplasm ResidualAdult; Aged; Aged; 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Laparoscopy; Middle Aged; Neoplasm Staging; Neoplasm; Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Tumor BurdenPopulationlaparoscopySurgical oncologyInternal medicineHumansMedicineeducationLaparoscopySurvival ratePeritoneal NeoplasmsAgedNeoplasm StagingRetrospective StudiesAged 80 and overOvarian Neoplasmseducation.field_of_studymedicine.diagnostic_testPerformance statusbusiness.industryMedicine (all)Retrospective cohort studyMiddle AgedPrognosismedicine.diseaseDebulkingCombined Modality TherapyTumor BurdenSurvival Rateovarian cancerSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologyFemaleSurgerybusinessOvarian cancerFollow-Up StudiesAnnals of Surgical Oncology
researchProduct

Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer

2007

Abstract Objective. Docetaxel and carboplatin are active in relapsed ovarian, peritoneal and tubal cancer. Recently, two prospective-randomized trials showed an advantage of carboplatin combination regimen with paclitaxel or gemcitabine over carboplatinum alone in platinum-sensitive cases. The question on the most effective combination with the best tolerable side effects still needs to be answered. Methods. Eligible patients had recurrent ovarian, peritoneal or tubal cancer (platinum-free interval >6 months), performance status 0–2 and normal bone marrow, renal and hepatic function. 25 patients (age 18–75 years) were enrolled into this phase II trial. Patients with debulking operation of r…

AdultOncologymedicine.medical_specialtyPopulationDocetaxelGastroenterologyDisease-Free SurvivalCarboplatinchemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineFallopian Tube NeoplasmsHumanseducationPeritoneal NeoplasmsAgedOvarian Neoplasmseducation.field_of_studyPerformance statusbusiness.industryObstetrics and GynecologyCancerMiddle AgedDebulkingmedicine.diseaseGemcitabineCarboplatinRegimenOncologyDocetaxelchemistryDrug Resistance NeoplasmFemaleTaxoidsNeoplasm Recurrence Localbusinessmedicine.drugGynecologic Oncology
researchProduct

Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?

2015

To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the first surgical assessment was performed.Retrospective analysis of primary AEOC patients was performed and three groups were formed based on where the decision of primary treatment was taken: Internal, if the decision was carried out at our Institution (PDS (Primary Debulking Surgery), I-IDS (Internal-Interval Debulking Surgery)) and Referred in case women were referred after neoadjuvant chemotherapy (NACT) from other Centers (R-IDS (Referred-Interval Debulking Surgery)).Among 573 AEOC, 279 (48.7%) were PDS and 294 (51.3%) IDS. In particular, 134 of 294 (45.6%) were R-IDS and 160 (54.4%) were I-IDS.…

AdultTertiary Care CenterCarcinoma Ovarian EpithelialDisease-Free SurvivalcytoreductionTertiary Care CentersOvarian cancerAntineoplastic Combined Chemotherapy ProtocolsHumansNeoplasms Glandular and EpithelialAgedNeoplasm StagingAged 80 and overOvarian NeoplasmsCytoreduction; Interval debulking surgery; Ovarian cancer; PrognosisClinical Trials as TopicAntineoplastic Combined Chemotherapy ProtocolOvarian NeoplasmMiddle AgedPrognosisNeoadjuvant TherapySettore MED/40 - GINECOLOGIA E OSTETRICIAinterval debulking surgeryFemaleprognosineoadjuvant chemotherapyHuman
researchProduct

Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center cl…

2022

Introduction: Ovarian cancer (OC) represent nearly 4% of gynecologic malignancies and it is often diagnosed at advanced stage. Diaphragmatic surgery, a fundamental step of advanced stage ovarian cancer (ASOC) debulking surgery, is associated with a high post-operative complication incidence, which is supposedly reduced with thoracostomy tube placement. We assessed the role of intra-operative thoracostomy tube placement, as a prevention measure for post-operative complications, after diaphragmatic resection. Methods: This was a single center prospective randomized trial. Ovarian cancer patients, who underwent mono-lateral diaphragmatic resection, were randomized 1:1 into two arms. Arm A incl…

Adultmedicine.medical_specialtyDiaphragmatic surgeryPleural effusionmedicine.medical_treatmentDiaphragmatic resectionDiaphragmDiaphragmatic breathingThoracentesisCarcinoma Ovarian EpithelialThoracostomySingle CenterPostoperative ComplicationsOvarian cancermedicineHumansAgedOvarian NeoplasmsIntraoperative CareCytoreduction Surgical ProcedureThoracostomy tubebusiness.industryOvarian NeoplasmObstetrics and GynecologyPneumothoraxCytoreduction Surgical ProceduresThoracostomy...Middle Agedmedicine.diseaseDebulkingThoracostomySurgeryPleural EffusionSettore MED/40 - GINECOLOGIA E OSTETRICIALogistic ModelsOncologyPneumothoraxChest TubesFemaleComplicationbusinessGynecologic oncology
researchProduct

Primary site disease and recurrence location in ovarian cancer patients undergoing primary debulking surgery vs. interval debulking surgery

2020

Introduction: The natural history and patterns of ovarian cancer (OC) relapse are still unclear. Recurrent disease can be peritoneal, parenchymal, or nodal. This study aims to analyze the location and pattern of OC recurrence according to the primary site of disease and to the type of surgical approach used. Material and methods: All OC patients underwent primary debulking surgery (PDS) or interval debulking surgery (IDS), with 2014 FIGO stage III-IV, and with platinum-sensitive recurrence were included in the study. Primary disease location and site of recurrences were divided into peritoneal, parenchymal, and nodal, according to the presence of peritoneal carcinomatosis, parenchymal metas…

Adultmedicine.medical_specialtyDiseaseMetastasis03 medical and health sciences0302 clinical medicineOvarian cancerRecurrenceMedicineHumans030212 general & internal medicineStage (cooking)Nodal involvementAgedOvarian Neoplasmsbusiness.industryGeneral MedicineCytoreduction Surgical ProceduresMiddle Agedmedicine.diseaseDebulkingSite of recurrencePeritoneal carcinomatosisSurgeryNatural historyNeoplasm RecurrenceOncologyLocalPrimary site location030220 oncology & carcinogenesisSurgeryFemaleNeoplasm Recurrence LocalPattern of recurrencebusinessOvarian cancer
researchProduct

The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: First experience with 18 patients

1992

CORT is a new radiosurgical treatment concept for patients with recurrent gynecologic malignancies infiltrating the pelvic wall. The operative part consists of (i) staging laparotomy; (ii) maximum debulking of the tumor from the pelvic wall and exenteration of infiltrated central pelvic organs; (iii) implantation of brachytherapy guiding tubes on the residual tumor/tumor bed at the pelvic wall; (iv) pelvic wall plasty with muscle and omentum flaps to create a protective distance between the tubes and the pelvic hollow organs and to induce therapeutic angiogenesis; and (v) surgical reconstruction of bowel, bladder, and vulvoperineovaginal functions. Radiation is given postoperatively as frac…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentBrachytherapyBrachytherapyWhole-PelvisPelvic wallHumansMedicineProspective StudiesPelvic NeoplasmsPelvic organbusiness.industryPrior RadiationOperative mortalityObstetrics and GynecologyRadiotherapy DosageGeneral MedicineMiddle AgedPrognosisDebulkingCombined Modality TherapySurgeryRadiation therapyOncologyFemalebusinessPelvic radiotherapyInternational Journal of Gynecology & Obstetrics
researchProduct

A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment

2016

Abstract Objective To develop and validate a simple adjusted laparoscopic score to predict major postoperative complications after primary debulking surgery (PDS) in advanced epithelial ovarian cancer (AEOC). Methods From January 2006 to June 2015, preoperative, intraoperative, and post-operative outcome data from patients undergoing staging laparoscopy (S-LPS) before receiving PDS (n=555) were prospectively collected in an electronic database and retrospectively analyzed. Major complications were defined as levels 3 to 5 of MSKCC classification. On the basis of a multivariate regression model, the score was developed using a random two-thirds of the population (n=370) and was validated on …

Adultmedicine.medical_specialtyPost-operative complicationsPopulationLaparoscopy; Ovarian cancer; Post-operative complications; Predictive model; Obstetrics and Gynecology; OncologyRisk AssessmentYoung Adult03 medical and health sciencesGynecologic Surgical ProceduresPostoperative Complications0302 clinical medicineOvarian cancerAscitesHumansMedicineMajor complicationLaparoscopy; Ovarian cancer; Post-operative complications; Predictive modelYoung adultLaparoscopyeducationAgedAged 80 and overOvarian Neoplasmseducation.field_of_studyModels Statistical030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryReproducibility of ResultsObstetrics and GynecologyMiddle Agedmedicine.diseaseDebulkingSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIAItalyOncologyPredictive model030220 oncology & carcinogenesisFemaleLaparoscopymedicine.symptombusinessOvarian cancerRisk assessment
researchProduct

Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept

2015

Abstract Objective To develop an updated laparoscopy-based model to predict incomplete cytoreduction (RT>0) in advanced epithelial ovarian cancer (AEOC), after the introduction of upper abdominal surgery (UAS). Patients and methods The presence of omental cake, peritoneal extensive carcinomatosis, diaphragmatic confluent carcinomatosis, bowel infiltration, stomach and/or spleen and/or lesser omentum infiltration, and superficial liver metastases was evaluated by staging laparoscopy (S-LPS) in a consecutive series of 234 women with newly diagnosed AEOC, receiving laparotomic PDS after S-LPS. Parameters showing a specificity≥75%, PPV≥50%, and NPV≥50% received 1 point score, with an additional…

Adultmedicine.medical_specialtymedicine.medical_treatmentOmental cakePredictive Value of TestCarcinoma Ovarian EpithelialModels BiologicallaparoscopicGynecologic Surgical ProceduresGynecologic Surgical ProcedureRetrospective StudiePredictive Value of TestsLaparotomymedicineHumansNeoplasms Glandular and EpithelialLaparoscopyAgedNeoplasm StagingRetrospective StudiesLesser omentumPrimary debulking surgeryAged 80 and overOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryStomachOvarian NeoplasmMedicine (all)Obstetrics and GynecologyBowel resectionMiddle Agedmedicine.diseaseAdvanced epithelial ovarian cancerSurgerymedicine.anatomical_structureovarian cancerSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologyPredictive value of testsFemaleLaparoscopyOvarian cancerbusinessHuman
researchProduct

Tuning the selectivity of molecularly imprinted polymer extraction of arylcyclohexylamines: From class-selective to specific

2020

Abstract A molecularly imprinted polymer (MIP) has been prepared in presence of 3-hydroxy phencyclidine (3-OH PCP) as template by bulk polymerization using N,N-dimethylformamide, as porogenic solvent, for the selective solid-phase extraction (SPE) of arylcyclohexylamines from oral fluids. Experimental variables of the extraction procedure have been studied in order to increase both, extraction recovery of 3-OH PCP, used as model analyte, and imprinting factor. By modifying the composition of the washing solvent, the selectivity of the MIP extraction procedure can be tuned, moving from an arylcyclohexylamine selective method to a 3-OH PCP specific method. The applicability of the synthesized…

AnalyteArylcyclohexylamineBulk polymerizationSurface PropertiesIon-mobility spectrometry02 engineering and technology01 natural sciencesBiochemistryPolymerizationAnalytical ChemistryMolecularly Imprinted PolymersIon Mobility SpectrometrymedicineEnvironmental ChemistryParticle SizeSpectroscopyDetection limitCyclohexylaminesChromatographyMolecular StructureChemistry010401 analytical chemistryMolecularly imprinted polymer021001 nanoscience & nanotechnology0104 chemical sciencesSolvent0210 nano-technologySelectivitymedicine.drugAnalytica Chimica Acta
researchProduct